14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.500 $0.700 Thursday, 2nd May 2024 ADXS stock ended at $0.531. This is 17.51% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 17.53% from a day low at $0.519 to a day high of $0.610.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Jan 18, 2022 $0.150 $0.157 $0.140 $0.153 520 200
Jan 14, 2022 $0.160 $0.162 $0.141 $0.157 997 700
Jan 13, 2022 $0.162 $0.162 $0.150 $0.160 267 200
Jan 12, 2022 $0.159 $0.162 $0.150 $0.160 1 204 200
Jan 11, 2022 $0.158 $0.164 $0.155 $0.155 2 448 400
Jan 10, 2022 $0.160 $0.160 $0.150 $0.157 2 372 800
Jan 07, 2022 $0.156 $0.174 $0.155 $0.164 391 600
Jan 06, 2022 $0.165 $0.174 $0.155 $0.163 761 100
Jan 05, 2022 $0.164 $0.177 $0.151 $0.162 1 034 400
Jan 04, 2022 $0.170 $0.188 $0.159 $0.169 2 402 457
Jan 03, 2022 $0.159 $0.170 $0.159 $0.169 2 402 457
Dec 31, 2021 $0.153 $0.160 $0.143 $0.156 1 444 533
Dec 30, 2021 $0.140 $0.162 $0.140 $0.150 2 324 027
Dec 29, 2021 $0.151 $0.160 $0.121 $0.147 7 882 838
Dec 28, 2021 $0.165 $0.165 $0.140 $0.151 4 987 394
Dec 27, 2021 $0.190 $0.195 $0.141 $0.163 10 381 153
Dec 23, 2021 $0.158 $0.200 $0.111 $0.200 26 997 127
Dec 22, 2021 $0.290 $0.290 $0.236 $0.240 16 314 180
Dec 21, 2021 $0.303 $0.303 $0.287 $0.294 3 310 239
Dec 20, 2021 $0.320 $0.320 $0.275 $0.296 3 764 784
Dec 17, 2021 $0.320 $0.328 $0.305 $0.325 2 393 657
Dec 16, 2021 $0.320 $0.330 $0.303 $0.310 1 486 139
Dec 15, 2021 $0.300 $0.325 $0.293 $0.317 1 725 094
Dec 14, 2021 $0.313 $0.330 $0.300 $0.309 2 782 762
Dec 13, 2021 $0.316 $0.330 $0.305 $0.313 1 810 384
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT